Table 1.
Patient characteristics and ME status
| Patients | ME positive | ||
|---|---|---|---|
| Characteristic | No (%) | % | P value |
| Age (y) | NS | ||
| ≤60 | 39 (51.3) | 87.2 | |
| >60 | 37 (48.7) | 73.0 | |
| Sex | NS | ||
| Male | 60 (78.9) | 78.3 | |
| Female | 16 (21.1) | 87.5 | |
| Status of Hepatitis | |||
| HBsAg positive | 62 (81.6) | 85.5 | NS |
| HCVAb positive | 3 (3.9) | 33.3 | |
| Others | 11 (14.5) | 63.6 | |
| AFP level (ng/ml) | <0.01 | ||
| Normal | 43 (56.6) | 69.8 | |
| Elevated | 33 (43.4) | 93.9 | |
| Tumor size (cm) | NS | ||
| ≤5 | 41 (53.9) | 78.0 | |
| >5 | 35 (46.1) | 82.9 | |
| TNM stage | NS | ||
| I | 42 (55.3) | 83.3 | |
| II | 34 (44.7) | 76.5 | |
| Platelets (G/L) | NS | ||
| <100 | 11 (14.5) | 81.8 | |
| ≥100 | 65 (85.5) | 80.0 | |
| AST level (U/L) | NS | ||
| ≤40 | 54 (71.1) | 85.2 | |
| >40 | 22 (28.9) | 68.2 | |
| ALT level (U/L) | NS | ||
| ≤40 | 49 (71.1) | 81.6 | |
| >40 | 27 (28.9) | 77.8 | |
| GGT level (U/L) | NS | ||
| ≤55 | 43 (56.6) | 81.4 | |
| >55 | 33 (43.4) | 78.8 | |
| Albumin level(g/L) | NS | ||
| ≤35 | 8 (10.5) | 75.0 | |
| >35 | 68 (89.5) | 80.9 | |
| BIL (μmol/L) | NS | ||
| ≤17.1 | 59 (77.6) | 78.0 | |
| >17.1 | 17 (22.4) | 88.2 | |
| PT(s) | NS | ||
| ≤13.3 | 55 (72.4) | 83.6 | |
| >13.3 | 21 (27.6) | 71.4 | |
| Tumor grade | <0.01 | ||
| 1 | 6 (7.9) | 16.7 | |
| 2 | 43 (56.6) | 79.1 | |
| 3 | 27 (35.5) | 96.3 | |
| All patients | 76 (100) | 80.3 | -- |
Abbreviations: HBsAg = hepatitis B surface antigen; HCV Ab = hepatitis C virus antibody; AFP = serum α-fetoprotein; AST = serum aspartate aminotransferase level; ALT = serum alanine aminotransferase level; GGT = serum γ-glutamyltransferase; BIL = serum total bilirubin level; PT = prothrombin time; NS = not significant.